Iran Peace Deal Could Open Strait of Hormuz Without Conditions Petraeus Suggests Berkshire Hathaway Revamps Portfolio New 26 Billion Delta Stake and Massive Alphabet Increase Financial Services Roundup Market Talks Highlight Experian and SoFi Technologies Mortgage Rates Remain Stubbornly High Despite Fed Rate Cut Whats Behind the Divergence Stock Markets Gain as USIran Talks Show Progress Treasury Yields Dip Wall Street Edges Higher as Consumer Rally Offsets Energy Drag YALA Q1 2026 Earnings Positive EPS of 016 Drives Modest Share Uptick Tompkins Financial Corporation TMP Q1 2026 Earnings EPS Beat of 277 Amid Steady Operating Performance Reynolds Consumer Products Q1 2026 Earnings EPS Surpasses Expectations by 136 Fortis Inc FTS Q1 2026 Earnings Modest EPS Miss Amid Steady Operations DDS Q1 2026 Earnings Earnings Miss Estimates Despite Positive Market Reaction Polaris PII Q1 2026 Earnings Significant EPS Beat Drives Positive Market Reaction Genelux Corporation GNLX Gains 3 Amid Renewed Interest Key Levels to Watch ICL Group ICL Edges Lower Consolidation Near Support Amidst Sector Headwinds Embraer EMBJ Rises 188 as Aerospace Sector Momentum Builds Atrium Therapeutics RNA Drops Slightly Amidst Market Caution Holds Above Support Aurinia Pharmaceuticals AUPH Retreats Testing Key Support After EarningsDriven Volatility Federal Realty Investment Trust Stock Tracks Market Closely Outperforms in 2026 Valley National Bancorp VLYPP Q1 2026 Earnings Small EPS Beat Despite Tepid Market Response Jefferies Financial Group JEF Holds Steady Near 5256 as Support and Resistance Define Trading Range CGTX Q1 2026 Earnings Cognition Therapeutics Reports NarrowerThanExpected Loss No Revenue Yet ETON Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges PHVS Q1 2026 Earnings Loss Narrower Than Expected as Pipeline Progress Continues SPB Q1 2026 Earnings EPS Surpasses Estimates by 127 Stock Declines 14 Biohaven BHVN Q1 2026 Earnings EPS Slightly Misses Estimates as Pipeline Momentum Builds IRT Earnings Overview 20260528 ZBIO Q1 2026 Earnings NarrowerThanExpected Loss as PreRevenue Biotech Advances Pipeline